84 results
Page 3 of 5
6-K
EX-1.1
ngkp295 62itqnxe9k
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
avq6bp2ts542ku
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
dyzt1wh563ak9 0ibs
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
3558l8 74
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
ljhrm h52w
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
ueyyx10s
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
6e5q4ck7dqwl 82
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
tw1d3rbae
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
73x3 98rf
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
yymgsh7 aa6
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
26g97
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.1
jjiwn0
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.2
bz00f s7b3l2ti9g466
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.1
epdg61so nz
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.2
mrvmwsf jpqdds
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
mab8lc
20 May 19
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
oax0uca6xatrj34gtsy9
20 May 19
Condensed Consolidated Financial Statements
4:15pm